药明生物(02269.HK) 今日(14日)高开3.6%报17.5元,现报17.8元,升5.33%,成交1,271.61万股,涉资2.23亿元。公司2025年度医疗健康大会简报披露,集团业务及财务状况依然强健,对去年实现预期收入增长充满信心,并预期今年收入将按年实现加速增长。集团去年新增151个项目,项目总数达817个。此外,于去年通过研究(R)平台赋能7个分子研究服务的全球项目,并有权于近期收取...
Source Link药明生物(02269.HK) 今日(14日)高开3.6%报17.5元,现报17.8元,升5.33%,成交1,271.61万股,涉资2.23亿元。公司2025年度医疗健康大会简报披露,集团业务及财务状况依然强健,对去年实现预期收入增长充满信心,并预期今年收入将按年实现加速增长。集团去年新增151个项目,项目总数达817个。此外,于去年通过研究(R)平台赋能7个分子研究服务的全球项目,并有权于近期收取...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.